Targeting RNA helicase DHX33 blocks Ras‐driven lung tumorigenesis in vivo

Ras has been found to be mutated in 30% of non‐small cell lung cancers, and its mutation has been regarded as a causal factor underlying tumorigenesis. However, no successful medicine has been developed so far to inhibit Ras for lung cancer treatment. We have previously identified DHX33 as a Ras dow...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Sci
Päätekijät: Wang, Xingshun, Feng, Weimin, Peng, Cheng, Chen, Shiyun, Ji, Hongbin, Zhong, Hanbing, Ge, Wei, Zhang, Yandong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Carcinogenesis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7540983/
https://ncbi.nlm.nih.gov/pubmed/32767810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14601
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia